Psychedelic and Plant Medicine Therapists, Practitioners, Providers
- psychedelic-institute-of-mental-health.ghost.io Psychedelic Cognitive Behavioral Therapy (Part 2: On Ketamine, Context and Competencies in "Assisted-Psychotherapy")
There are many tools to help a psychotherapist help clients learn to speak the language of cognitive behavioral therapy, especially tools which may help facilitate a connection, including, but not limited to telehealth.
-
Oral ketamine effects on dynamics of functional network connectivity in patients treated for chronic suicidality (Shan, et al, 2024)
toad.social PlanetMedicines (@[email protected])Attached: 1 image https://pubmed.ncbi.nlm.nih.gov/38772940/ Oral ketamine effects on dynamics of functional network connectivity in patients treated for chronic suicidality (Shan, et al, 2024) #ketamine #psychedelic #research #psychedelics #ketamineassistedpsychotherapy #psychedelicassistedpsychoth...
- flip.it Some psychedelic medicine developers want to ditch the therapy aspect. What could go wrong?
Are drugs like psilocybin and MDMA still safe and effective in the absence of psychotherapy?
-
How to double blind MDMA for PTSD? Ketamine!
toad.social PlanetMedicines (@[email protected])Attached: 1 image Hey #mdma for #ptsd researchers. CBT and EMDR with and without medicine with #ketamine by mouth as the active placebo. And compare these to sertraline and paroxetine with and without CBT/EMDR then do crossover arms. This is not difficult. #fda #psychedelics #psychedelicresearch #p...
- psychedelic-institute-of-mental-health.ghost.io Does the "psychedelic experience" matter?
Part 3 Psychedelic as experience that when experienced, seems to help people profoundly more often than it harms people irreparably Although working on many different parts and systems in the brain, some overlapping with serotonergic psychedelics, some not, the experience and its effects have be...
-
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data (Mathai, et al, 2024)
toad.social PlanetMedicines (@[email protected])https://psychedelictherapy.institute/ketamine-research-1/at-home-ketamine-therapy At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data (Mathai, et al, 2024) #ketamine #psychedelics #psychedelicre...
-
Study models how ketamine’s molecular action leads to its effects on the brain (2024)
picower.mit.edu Study models how ketamine’s molecular action leads to its effects on the brainNew research addresses a gap in understanding how ketamine’s impact on individual neurons leads to pervasive and profound changes in brain network function.
-
California Kills Psychedelic Bill: The Regulated Psychedelic Facilitators Act and the Regulated Psychedelic-Assisted Therapy Act
> > > Bill killed May 16th https://www.yahoo.com/news/california-lawmakers-kill-psychedelics-legalization-220852017.html
-
Event: June 27, 2024– FDA hosts “Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest”
reaganudall.org Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest | Reagan-Udall FoundationThe Reagan-Udall Foundation for the FDA, in collaboration with the FDA, is hosting a hybrid public workshop on "Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest."
-
Psilocybin adverse effects mostly resolve within 2 days (Harris, 2024)
toad.social PlanetMedicines (@[email protected])Attached: 1 image Therapeutic Psilocybin's Adverse Effects Mostly Resolved Within 2 Days (Harris, 2024) https://jamanetwork.com/journals/jama/fullarticle/2818439 #psilocybin #psychedelicresearch #psychedelics #plantmedicine #psychedelictherapy #adverseeffects
-
International Ketamine Conference in Oxford debates ketamine at home, with majority agreeing at home ketamine is safe, when addressing risks
toad.social PlanetMedicines (@[email protected])Attached: 1 image #ketamine At home ketamine can be safe. Working with a licensed psychotherapist through a course of ketamine-assisted psychotherapy is one way to decrease risk. (2024) https://www.biospace.com/article/opinion-can-ketamine-be-safely-used-at-home-/ #psychedelics #psychedelicresearch...
-
Psychedelic Cognitive Behavioral Therapy (an ongoing review - part 1)
psychedelic-institute-of-mental-health.ghost.io Psychedelic Cognitive Behavioral TherapyAn evolving overview of cognitive behavioral therapy in psychedelic-assisted psychotherapy and ketamine psychedelic therapy. Part I Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default (Yaden, et al, 2022) "Our primary reasons for advocating for cognitive-behavioral ap...
-
Childhood trauma and challenging ayahuasca experiences
flip.it Is childhood trauma linked to challenging ayahuasca experiences? New study has surprising answerA recent study found no link between trauma history and the severity of psychedelic challenges or subsequent psychological growth, suggesting individual reactions to ayahuasca are highly variable.
-
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial (Levin, et al, 2024)
journals.plos.org The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorderWe examined if the therapeutic alliance between study participants and intervention facilitators in a psilocybin-assisted therapy (PAT) trial changed over time and whether there were relationships between alliance, acute psilocybin experiences, and depression outcomes. In a randomized, waiting list-...
Psychedelic medicines have been studied as an adjunct to psychotherapy for over 100 years.
-
Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine (Evans, et al 2024)
pubmed.ncbi.nlm.nih.gov Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine - PubMedKetamine's comprehensive clinical profile, combined with its robust effects on depression, suicidal ideation, PTSD, chronic pain, and other psychiatric conditions, positions it as a substantial contender for transformative therapeutic application.
-
Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis (Kwan, et al, 2024)
pubmed.ncbi.nlm.nih.gov Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis - PubMedHerein, we determined that the NNT for ketamine treatment in adults living with TRD across different intervals of observation was <10. We conclude that the NNTs observed herein are highly clinically meaningful in this difficult to treat disorder.
-
Investigating the effectiveness of oral ketamine on pain, mood and quality of life in treatment resistant chronic pain (al Mukhaizeem, et al, 2023)
pubmed.ncbi.nlm.nih.gov Investigating the effectiveness of oral ketamine on pain, mood and quality of life in treatment resistant chronic pain - PubMedThis real-world study shows that patients being treated with oral ketamine for chronic pain report decreased severity of pain, improved mood and increased quality of life across all conditions.
cross-posted from: https://lemmy.world/post/14433382
> “ Discussion: This work adds to the growing body of evidence that under the supervision of a pain specialist, oral ketamine therapy may be a safe, tolerable and effective treatment for chronic pain conditions which have not responded to other management options. Further research is required to produce a more accurate understanding of its chronic use. > > Key message: This real-world study shows that patients being treated with oral ketamine for chronic pain report decreased severity of pain, improved mood and increased quality of life across all conditions.” > > Note- this study included patients taking ketamine by mouth for up to 12 years.
-
Ketamine induces multiple individually distinct whole-brain functional connectivity signatures (Moujaes, et al, 2024)
elifesciences.org Ketamine induces multiple individually distinct whole-brain functional connectivity signaturesThere is substantial individual variation in behavioral and neural responses to acute ketamine administration in healthy controls, which emphasises the need for personalized approaches when harnessing ketamine as a treatment for depression.
cross-posted from: https://lemmy.world/post/14411345
> This paper presents a valuable investigation of the acute effects of ketamine in healthy volunteers using rating scale-based behavioral and resting-state fMRI-based neural measures. It provides solid evidence of inter-individual variability in responses to ketamine along with associations to relevant gene expression markers (somatostatin, parvalbumin) in the brain. >
-
Event: Psilocybin Therapy for Bipolar Disorder ⏰ Tuesday 16 April, 8PM CET (7PM GMT, 2PM EST, 11AM PST)
open-foundation.org Psilocybin Therapy for Bipolar DisorderResearchers at Maryland University have completed an early phase clinical trial to asses the feasibility and preliminary outcomes of treating Bipolar II Disorder with single-dose synthetic psilocybin. Specifically, this recently published study treated patients with a BD II diagnosis in a current de...
-
The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A worldwide overview (2019)
toad.social PlanetMedicines (@[email protected])Attached: 1 image The oldest archeological data evidencing the relationship of Homo sapiens with psychoactive plants: A worldwide overview (2019) https://akjournals.com/view/journals/2054/3/2/article-p63.xml #psychedelics #psychedelic #plantmedicine #history
-
California Psychedelic Wellness & Healing Initiative of 2024
www.pw4ca.com Home - Psychedelic Wellness & Healing Initiative of 2024Our Purpose To ensure that Californians have the right to obtain and use Entheogenic Substances for medical, therapeutic and spiritual purposes where the medical and therapeutic use is deemed appropriate and has been recommended by a physician, nurse practitioner, or licensed counseling therapist, w...
-
Matthew Perry + Ketamine 🔎 Here's What Really Happened
doubleblindmag.com Matthew Perry's Death Proves We Don't Know Much About KetamineSome experts believe Matthew Perry would still be alive if he didn't get into a pool on a high dose of ketamine.
-
Psilocybin Administration for Therapist Training: Outcomes from a World-First Study (2024)
m.youtube.com Psilocybin Administration for Therapist Training: Outcomes from a World-First StudyINSIGHT 2023 Replay from Therapist Training track:Dr. Paul Liknaitzky discusses findings from a proof-of-concept study determining the use of psilocybin as p...
-
NRx Pharmaceuticals Completes Memorandum of Understanding and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)
finance.yahoo.com NRx Pharmaceuticals (NASDAQ:NRXP) Completes Memorandum of Understanding and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company") and its wholly owned subsidiary HOPE Therapeutics, clinical-stage biopharmaceutical companies, today announced completion of a Memorandum of Understanding with Conversio Health, a national 503a pharmacy, and a strong, on...
-
Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder (Weiss, et al, 2024)
toad.social PlanetMedicines (@[email protected])Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder (Weiss, et al, 2024) https://ketaminetherapypalmsprings.com/psilocybinassisted-therapy/psilocybin-therapy-psychedelic-experience #psilocybin #psychedelic #thepsyc...
-
Ketamine Assisted Psychotherapy & Support— Training Practicum
An up-to-date, ongoing analysis and practical application of the 60+ years of ketamine research (Open to Clinicians and Non-Clinicians)
Introduction to cognitive behavioral therapy for psychotherapeutic care and support, an 8 week model of working with clients undergoing self-administered sublingual ketamine in collaboration with referring medical and mental health providers
Current and historical paradigms in ketamine-assisted psychotherapy (psycholytic through psychedelic) and its context within general psychedelic-assisted psychotherapy, including adverse effects, scope of practice vs scope of competency
Internal Family Systems (IFS) and story-telling to prepare for the 4 types of ketamine experiences and in integration of these experiences to maximize ongoing positive effects
A multicultural, existential and secular approach to ketamine psychedelic integration, which honors and is informed by the wisdom of cultures who have safely worked with these medicines and experiences throughout time balanced with cutting-edge research in cognitive behavioral therapy, metacognition and the 100+ year intersection of human psychology and psychedelic plant medicines and synthetic psychedelics like ketamine, LSD, and MDMA
Using technology— tools to monitor progress, at-home KAP setup, in-office KAP setup, ethical considerations in social media, advertising & AI, sound and technodelic applications in ketamine-assisted psychotherapy and non-medicine psychedelic experiences
Socratic Learning— Peer-practiced experientials with the various forms of racemic ketamine patients may be working with, in the dosing ranges standard in at-home, sublingual ketamine therapy, under the direction of a licensed mental health provider and an on-call medical provider after proper medical and mental health screening.
Practice- You will sit 6-12 times (minimum) with the medicine as both a client, and as a support to the client, using the same integration process as clients
Didactic lectures— guest speakers working in the field with specialties in psychopharmacology, medicine, and mental health.
- ir.mindmed.co MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
-A single oral administration of MM120 100 µg met its key secondary endpoint and maintained a clinically and statistically significant…...
-
Introducing psychedelics to end-of-life mental healthcare (Marks, et al 2023)
www.nature.com Introducing psychedelics to end-of-life mental healthcare - Nature Mental HealthEarly evidence suggests psychedelics could help alleviate end-of-life anxiety and depression. Yet there has been little study or discussion of their integration into hospice and palliative care settings, where patients often have complex comorbidities and medication regimens. The authors discuss rel...
-
Ketamine’s rapid and sustained antidepressant effects are driven by distinct mechanisms (Rawat, et al, 2024) - Cellular and Molecular Life Sciences
link.springer.com Ketamine’s rapid and sustained antidepressant effects are driven by distinct mechanisms - Cellular and Molecular Life SciencesAdministration of multiple subanesthetic doses of ketamine increases the duration of antidepressant effects relative to a single ketamine dose, but the mechanisms mediating this sustained effect are unclear. Here, we demonstrate that ketamine’s rapid and sustained effects on affective behavior are m...
- www.marijuanamoment.net Missouri Senators Approve Bill To Legalize Psilocybin Therapy For Veterans - Marijuana Moment
A Missouri Senate committee has approved a Republican-led bill to legalize the medical use of psilocybin by military veterans and fund studies exploring the therapeutic potential of the psychedelic. The Senate Emerging Issues Committee passed the legislation from Sen. Holly Thompson Rehder (R), with...
- finance.yahoo.com SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of i...
-
Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain (Vohryzek, et al, 2024)
academic.oup.com Brain dynamics predictive of response to psilocybin for treatment-resistant depressionVohryzek et al. investigated the effects of psilocybin therapy on depression. They employed brain modelling and uncovered crucial regions involved in restoring
-
Try psychedelics. Access transcendence. | James Fadiman
YouTube Video
Click to view this content.
-
Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach (Wolfson & Vaid, 2024)
www.frontiersin.org Frontiers | Ketamine-assisted psychotherapy, psychedelic methodologies, and the impregnable value of the subjective—a new and evolving approach<p>Psychiatry is in a growth phase in which several psychedelic medicines have entered its arena with great promise. Of these, presently, ketamine is the onl...</p>
-
Feb 28th, 2024: How can we integrate Indigenous people into academic research on psychedelics? (online)
www.crowdcast.io How can we integrate Indigenous people into academic research on psychedelics?Register now for How can we integrate Indigenous people into academic research on psychedelics? on crowdcast, scheduled to go live on February 28, 2024, 12:00 PM PST.
-
Development and psychometric validation of a novel scale for measuring 'psychedelic preparedness' (2024) #psychedelic #psychedelicresearch
toad.social PlanetMedicines (@[email protected])Attached: 1 image Development and psychometric validation of a novel scale for measuring 'psychedelic preparedness' (2024) #psychedelic #psychedelicresearch https://pubmed.ncbi.nlm.nih.gov/38332334/